Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

There is an urgent unmet need for digital mental health interventions specifically designed for individuals suffering from Long COVID. In this research, we will evaluate a new digital intervention program designed specifically for those experiencing persistent mental health symptoms such as anxiety, depression, trauma, or cognitive dysfunction following COVID-19 infection. The intervention (called Toivoa-004) was created to meet the accessibility and personalization needs of this population and to introduce and measure the clinical impact of a cognitive behavioral therapy intervention combined with mental health coaching, tailored to the unique challenges faced by Long COVID patients and their caregivers.

Primary Objective: Assess the feasibility of participants remaining active users of the Toivoa-004 digital therapeutic over the 12-week study period. Active use will be described in terms of engagement with the platform's core modules as tracked by system analytics.

Exploratory Objective: Explore the usability, ease of use, and acceptability of Toivoa-004 by evaluating engagement with core therapeutic components. Data include usage metrics, satisfaction ratings, and qualitative feedback through in-app surveys and interviews.

Inclusion criteria

• Provision of signed and dated informed consent form.
• Presence of clinically diagnosed Long COVID.
• Stated willingness to comply with all study procedures and lifestyle considerations, and availability for the duration of the study.
• Males and females; Age 22 and above.
• Clinical Diagnosis of Long COVID
• Willingness to adhere to the study regiment.
• Access to necessary resources for participating in a technology-based intervention (i.e., Phone, internet access).
• Able to read and speak English fluently.
• Resident of the US and living in the US for the duration of the study.

__________________________

Exclusion criteria

• Self-reported substance use disorder. In the past 12 months (not including tobacco).
• Self-reported suicide attempts in the past year or elevated suicide risk other than passive ideation (i.e., endorsing items reflecting intent, identifying means, suicide planning, or suicide-related preparations).
• Currently pregnant or planning to become pregnant during the treatment period.